Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Comment by rjc7on Jan 16, 2016 9:05am

101 Views

Post# 24464713

RE:RE:Here's What MBX Needs To Do For Shareholders

I agree with your line of thinking except the shareholders have been hearing for too long about the pipeline that that's all they care about and want to hear about. Any core business advancement gets lost and is treated as non event. The market wants a decision on Lunisort - pure and simple.

Bullboard Posts

Anaergia expands relationship with PepsiCo